(2)
LOS ANGELES, CA / ACCESSWIRE / January 19, 2021 / Cannabis Global, Inc. (OTC PINK:CBGL), an innovation-oriented company investing in disruptive cannabis and hemp-related technologies, today announces the filing of a new patent on a unique method to produce water-soluble cannabinoids. The patent announced today relates to a composition comprising one or more cannabosides and a method of producing one or more cannabosides. In particular, by feeding an insect a cannabinoid and harvesting the insect, excluding honey bees, to improve aqueous solubility and stability of cannabinoids. The patent claims coverage of both the process to create the compounds, and the use of the compounds in foodstuffs and pharmaceutical preparations.
To print this article, all you need is to be registered or login on Mondaq.com.
After 12 years waiting, the 4th version of the Chinese
Patent Law with an aim of further motivating innovations and
improving the mechanism for cracking down patent infringements was
finally passed by China s top legislature on October 17, 2020.
The amended Chinese patent law will take effect on
June
1, 2021. We outline some of important changes
below:
a. Changes that Aim to Improve Patent Prosecution
Partial design is finally introduced
into the Chinese patent system;
The protection period for design patent will be extended to
15 years, in preparation to join the Hague
Sanitise your hands the digital way
Updated:
Updated:
Startup mentored by SKU develops ‘liquid-free sanitiser’
Share Article
AAA
Startup mentored by SKU develops ‘liquid-free sanitiser’
At a time when the use of liquid sanitisers has become a routine for all in wake of coronavirus pandemic, a startup mentored by Sri Krishnadevaraya University as part of the Atal Innovation Mission has come up with a solution for disinfecting hands without any alcohol-based liquid.
Suchandra Technologies Private Limited has come up with ‘WizCleanzer’ that has been developed by five engineering undergraduates of Bengaluru-based R.V. College of Engineering.
“The startup has been registered with the Ministry of Corporate Affairs and the e-sanitiser has got a patent in India, besides being approved by the National Accreditation Board for Testing and Calibration Laboratories (NABL). A patent application is pending in the U.S.A.,” says Sandesh Krishna Sheety, one of the co-founde
Enzolytics, Inc. Receives Official Filing Receipt for Multiple Sclerosis Patent Application
Third Tranche of $1.2 Million Financing Completed
COLLEGE STATION, TX / ACCESSWIRE / January 19, 2021 / Enzolytics, Inc. (OTC PINK:ENZC)(the Company ) today, announced it has received the official filing receipt from the U.S. Patent Office confirming the filing of its patent application for Nuclear Proteins Isolated from Mammalian Spinal Cord Immune Factor - Pharmaceutical Composition for Treatment and has received the third tranche of the $1.2 million dollar financing.
The Company expects to file the disclosure section of the Annual Report pursuant to the Pink Basic Disclosure Guidelines by Tuesday afternoon. To maintain a current status with OTC Markets, the Company plans on filing the Financial Statements section of the Annual Report as well under the Pink Guidelines while the Audits for the December 31, 2020 and 2019 calendar year ends are completed.
To print this article, all you need is to be registered or login on Mondaq.com.
According to the Chinese Patent Law and practice,
means-plus-function claims are interpreted differently at the time
of Chinese patent prosecution and Chinese patent litigation.
Basically, while means-plus-function claims are
interpreted as
any means that could achieve the
function by examiner(s) during patent examination
(i.e.,
a broad claim that is difficult to be granted), such
claims are merely interpreted as
embodiments
disclosed in the Specification, or equivalent
thereof by the judge(s) during patent litigation
(i.e.,
a relatively narrow claim that makes it difficult to